These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23451236)

  • 1. The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma.
    Lee DW; Ramakrishnan D; Valenta J; Parney IF; Bayless KJ; Sitcheran R
    PLoS One; 2013; 8(2):e57489. PubMed ID: 23451236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
    Cherry EM; Lee DW; Jung JU; Sitcheran R
    Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression.
    Wang M; Zhang Y; Xu Z; Qian P; Sun W; Wang X; Jian Z; Xia T; Xu Y; Tang J
    Cell Commun Signal; 2020 Aug; 18(1):128. PubMed ID: 32807176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
    Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
    J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RelB/p50 complexes regulate cytokine-induced YKL-40 expression.
    Bhardwaj R; Yester JW; Singh SK; Biswas DD; Surace MJ; Waters MR; Hauser KF; Yao Z; Boyce BF; Kordula T
    J Immunol; 2015 Mar; 194(6):2862-70. PubMed ID: 25681350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lineage-Restricted OLIG2-RTK Signaling Governs the Molecular Subtype of Glioma Stem-like Cells.
    Kupp R; Shtayer L; Tien AC; Szeto E; Sanai N; Rowitch DH; Mehta S
    Cell Rep; 2016 Sep; 16(11):2838-2845. PubMed ID: 27626655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative NF-κB signaling promotes colorectal tumorigenesis through transcriptionally upregulating Bcl-3.
    Tao Y; Liu Z; Hou Y; Wang S; Liu S; Jiang Y; Tan D; Ge Q; Li C; Hu Y; Liu Z; Chen X; Wang Q; Wang M; Zhang X
    Oncogene; 2018 Nov; 37(44):5887-5900. PubMed ID: 29973688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RTVP-1 promotes mesenchymal transformation of glioma via a STAT-3/IL-6-dependent positive feedback loop.
    Giladi ND; Ziv-Av A; Lee HK; Finniss S; Cazacu S; Xiang C; Waldman Ben-Asher H; deCarvalho A; Mikkelsen T; Poisson L; Brodie C
    Oncotarget; 2015 Sep; 6(26):22680-97. PubMed ID: 26267319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of the expression of PPP3CC by ZEB1 confers activation of NF-κB and contributes to invasion and growth in glioma cells.
    Wang H; Zhao S; Chen B; Fu C; Dang Y; Fang P; Wang J; Wang N; Liu L
    Jpn J Clin Oncol; 2018 Feb; 48(2):175-183. PubMed ID: 29294030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of NF-κB and FOSL1 drives glioma stemness.
    Ramar V; Guo S; Hudson B; Khedri A; Guo AA; Li J; Liu M
    Cell Mol Life Sci; 2024 Jun; 81(1):255. PubMed ID: 38856747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-κB/IκBα negative feedback loop.
    Jiang L; Lin C; Song L; Wu J; Chen B; Ying Z; Fang L; Yan X; He M; Li J; Li M
    J Clin Invest; 2012 Jan; 122(1):33-47. PubMed ID: 22156201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF-κB positive feedback loop.
    Tu Y; Xie P; Du X; Fan L; Bao Z; Sun G; Zhao P; Chao H; Li C; Zeng A; Pan M; Ji J
    J Cell Mol Med; 2019 Oct; 23(10):6907-6918. PubMed ID: 31430050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RelB/NF-κB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis.
    Ge QL; Liu SH; Ai ZH; Tao MF; Ma L; Wen SY; Dai M; Liu F; Liu HS; Jiang RZ; Xue ZW; Jiang YH; Sun XH; Hu YM; Zhao YX; Chen X; Tao Y; Zhu XL; Ding WJ; Yang BQ; Liu DD; Zhang XR; Teng YC
    Cell Death Dis; 2016 Oct; 7(10):e2402. PubMed ID: 27711077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
    Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H
    Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LGR5 is a proneural factor and is regulated by OLIG2 in glioma stem-like cells.
    Mao XG; Song SJ; Xue XY; Yan M; Wang L; Lin W; Guo G; Zhang X
    Cell Mol Neurobiol; 2013 Aug; 33(6):851-65. PubMed ID: 23793848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Netrin-1 promotes glioma growth by activating NF-κB via UNC5A.
    Chen JY; He XX; Ma C; Wu XM; Wan XL; Xing ZK; Pei QQ; Dong XP; Liu DX; Xiong WC; Zhu XJ
    Sci Rep; 2017 Jul; 7(1):5454. PubMed ID: 28710382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An NF-κB signature predicts low-grade glioma prognosis: a precision medicine approach based on patient-derived stem cells.
    Ius T; Ciani Y; Ruaro ME; Isola M; Sorrentino M; Bulfoni M; Candotti V; Correcig C; Bourkoula E; Manini I; Pegolo E; Mangoni D; Marzinotto S; Radovic S; Toffoletto B; Caponnetto F; Zanello A; Mariuzzi L; Di Loreto C; Beltrami AP; Piazza S; Skrap M; Cesselli D
    Neuro Oncol; 2018 May; 20(6):776-787. PubMed ID: 29228370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the bHLH transcriptional networks by mutated E proteins in experimental glioma.
    Beyeler S; Joly S; Fries M; Obermair FJ; Burn F; Mehmood R; Tabatabai G; Raineteau O
    Stem Cells; 2014 Oct; 32(10):2583-95. PubMed ID: 24965159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion.
    Edwards LA; Woolard K; Son MJ; Li A; Lee J; Ene C; Mantey SA; Maric D; Song H; Belova G; Jensen RT; Zhang W; Fine HA
    J Natl Cancer Inst; 2011 Aug; 103(15):1162-78. PubMed ID: 21771732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TGFβ1-induced beta-site APP-cleaving enzyme 2 upregulation promotes tumorigenesis through the NF-κB signalling pathway in human gliomas.
    Wang H; Chen Z; Wang S; Gao X; Qian M; Qiu W; Zhang Z; Zhang S; Qi Y; Sun X; Xue H; Guo X; Zhao R; Li G
    Mol Oncol; 2020 Feb; 14(2):407-425. PubMed ID: 31856384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.